|
|
Dear colleague,
Want to know why VIB Technologies is more than just a toolbox? Interested in discovering the key to a healthy aging brain? Wondering what our spin-off
companies have been doing lately? And curious to meet our new group leaders? Well, you are in luck. I am more than happy to help answer these questions by sharing our latest news.
Kind regards,
Inge Boets (Communications Director at VIB)
|
|
|
|
 |
More than a technology toolbox |
|
|
VIB Technologies brings highly complex, novel technologies to researchers – and unites researchers across disciplines – to achieve scientific breakthroughs. “We offer much more than just a technology toolbox,” explains Saskia Lippens, Associate Technology Director at VIB. “We are the glue that connects scientists, Core Facilities and research centers around cutting-edge technology.”
|
 |
|
|
|
|
VIB launches its Data Core to provide researchers the tools to manage the increasing amount of data generated in life sciences research. Frederik
Coppens, Head of VIB’s Data Core: “By building and reinforcing our dedicated data infrastructure services, we aim to increase standardization rates, reproducibility of data and of course data quality.”
|
|
|
|
|
 |
What is the key to a healthy aging brain? |
As people age, they often experience problems with their memory and cognitive abilities. This happens in part because their brains become mildly inflamed. But there may be a solution: a small group of special immune cells, called regulatory T cells, could help reduce this inflammation in aging brains. Targeting the immune system might keep people’s brains healthy as they age.
|
|
|
|
Decoding the satiety signal |
|
|
The protein hormone leptin signals our brains that we are full and can stop eating. To send that signal, leptin has to bind to a receptor on the cells that need to receive the message. Research has now revealed how leptin and its receptor work together. These results may spark new approaches in treating obesity, a major metabolic condition worldwide.
|
|
|
|
|
Our spin-off companies in the spotlight
|
|
|
Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors, announced a licensing agreement with Eli Lilly and Company for Confo’s clinical stage CFTX-1554 and back-up compounds.
|
|
|
|
Augustine Tx will continue its work on delivering treatments for the Charcot-Marie-Tooth disease, thanks to the financial support of the Charcot-Marie-Tooth Research Foundation, a USA patient organisation.
|
|
|
MRM Health, focused on developing next-generation live microbiome consortia therapeutics, provided a business update on its different ongoing therapeutic programs and an outlook for 2023.
|
|
|
|
|
VIB @VIBLifeSciences · Apr 13
🤔 What's next for #sequencing technology? @ToonSwings talked about it with Shawn Levy, CSO at @ElemBio, during #RNGS23. Curious about his insights on next-generation sequencing? Read the interview in our new blog post 👇 #VIBTechnologies
|
 |
|
|
|
|
Warm welcome to our new group leaders |
|
|
Emanuela - Manu - Pasciuto started her first lab of Neuroimmunology at the VIB-UAntwerp Center for Molecular Neurology in April 2023. Her enthusiasm is already palpable. Manu: "I want to make a change in the field of neuroimmunology. I feel very lucky that I was able to start working on that during my time here, but now’s my chance to really try and make a difference.”
|
|
|
|
Also welcome to Pedro Gonçalves, our new group leader at NERF (empowered by imec, VIB, and KU Leuven). The Portuguese scientist will move from Germany to Leuven to
start his lab in Computational Neuroscience. He is actively seeking postdoctoral candidates and PhD students to join his team and collaborate on developing and applying machine learning methods to obtain mechanistic insights in neuroscience.
|
|
|
|
|
Meet us at the following events |
|
|
|
|
|
|
|
Unsubscribe
VIB, Suzanne Tassierstraat 1 , 9052 Ghent, Belgium |
|
|
|
|
